APA (7th ed.) Citation

V, M., D, M., J, D., S, T., A, S., K, K., . . . P, A. (2026). Dengue virus non-structural protein 1 as a surrogate biomarker of antiviral efficacy in early phase clinical trials. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 381(1949), . https://doi.org/10.1098/rstb.2024.0345

Chicago Style (17th ed.) Citation

V, Metem, et al. "Dengue Virus Non-structural Protein 1 as a Surrogate Biomarker of Antiviral Efficacy in Early Phase Clinical Trials." Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 381, no. 1949 (2026). https://doi.org/10.1098/rstb.2024.0345.

MLA (9th ed.) Citation

V, Metem, et al. "Dengue Virus Non-structural Protein 1 as a Surrogate Biomarker of Antiviral Efficacy in Early Phase Clinical Trials." Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, vol. 381, no. 1949, 2026, https://doi.org/10.1098/rstb.2024.0345.